- Home
- / Neuland Laboratories
Neuland Laboratories
Stock Price
₹13.9 K
2024-10-29
Market Capitalization
₹180.3 B
2024-10-29
Revenue
₹14.3 B
FY, 2025
Neuland Laboratories Summary
Company Summary
- Overview
- Neuland Laboratories is a provider of API manufacturing, and contract research and manufacturing services. It offers active pharmaceutical ingredients and end-to-end chemistry-related solutions for the pharmaceutical industry.
- Type
- Public
- Status
- Active
- Founded
- 1984
- HQ
- Hyderabad, IN | view all locations
- Website
- https://www.neulandlabs.com
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Christopher M. Cimarusti, Non-Executive Director
Humayun Dhanrajgir, Independent Director
Parampally Vasudeva Maiya, Independent Director
LocationsView all
7 locations detected
Hyderabad, TG HQ
India
8-2-112/120/1, KSR मार्ग, Venkat Nagar, Banjara Hills
Princeton, NJ
United States
116 Village Blvd #312
San Clemente, CA
United States
235 Calle Campesino
Hyderabad, TG
India
CCC6+6C2, Navanirman Nagar Colony, Film Nagar
Hyderabad, TG
India
Tower – B,Financial District, Nanakramguda, selenium, Plot No 31 & 32, Rd Number 1, Financial District, Gachibowli
Mumbai, MH
India
Lal Bahadur Shastri Rd, Surya Nagar, Chandan Nagar, Vikhroli West
Neuland Laboratories Financials
Summary Financials
- Revenue (Q3, 2026)
- ₹4.4B
- Gross profit (Q3, 2026)
- ₹2.6B
- Net income (Q3, 2026)
- ₹405.7M
- Cash (FY, 2026)
- ₹3.5B
- EBIT (Q3, 2026)
- ₹612.7M
- Enterprise value
- $179.7B